The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outpatient practice pattern and remote patient monitoring for axicabtagene ciloleucel CAR-T therapy in patients with aggressive lymphoma.
 
Radhika Bansal
No Relationships to Disclose
 
Jonas Paludo
Research Funding - Verily (Inst)
Other Relationship - Jazz Pharmaceuticals (Inst)
 
Adam Holland
No Relationships to Disclose
 
Spychalla Megan
No Relationships to Disclose
 
McClanahan Alli
No Relationships to Disclose
 
Matthew Hathcock
No Relationships to Disclose
 
Hassan Alkhateeb
No Relationships to Disclose
 
David Dingli
No Relationships to Disclose
 
Yucai Wang
Consulting or Advisory Role - Loxo (Inst)
Research Funding - Genentech (Inst); Incyte (Inst); InnoCare (Inst); Novartis (Inst)
 
Saad Kenderian
Stock and Other Ownership Interests - LEAH Labs; Mettaforge Therapeutics
Consulting or Advisory Role - Humanigen; Juno/Bristol-Myers Sqibb; Kite/Gilead; LEAH Labs; Novartis; SAB-Pharma
Research Funding - Humanigen; Juno/Bristol-Myers Sqibb; Kite/Gilead; LEAH Labs; Lentigen; MorphoSys; Novartis; Sunesis Pharmaceuticals; Tolero Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Humanigen; Mettaforge Therapeutics; MorphoSys; Novartis; Tolero Pharmaceuticals
 
Shaji Kumar
Consulting or Advisory Role - Abbvie (Inst); Abbvie (Inst); Amgen (Inst); Bluebird Bio (Inst); Celgene (Inst); Cellectar; Genecentrix; Genentech/Roche (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); Merck (Inst); Molecular Partners (Inst); Oncopeptides; Takeda (Inst)
Research Funding - Abbvie (Inst); CARsgen Therapeutics (Inst); Celgene (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst); Sanofi (Inst); Takeda (Inst); TeneoBio (Inst)
 
Mithun Vinod Shah
Consulting or Advisory Role - DAAN Biotherapeutics
Research Funding - Archer
 
Siddiqui Mustaqeem
No Relationships to Disclose
 
Rahma M. Warsame
No Relationships to Disclose
 
Jose Caetano Villasboas
Consulting or Advisory Role - Kite/Gilead (Inst); Regeneron (Inst)
 
Nabila Nora Bennani
Consulting or Advisory Role - Daiichi Sankyo; Kyowa Kirin
 
Patrick B. Johnston
No Relationships to Disclose
 
Stephen M. Ansell
Honoraria - Research to Practice; WebMD
Research Funding - ADC Therapeutics (Inst); Affimed Therapeutics (Inst); AI Therapeutics (Inst); Bristol-Myers Squibb (Inst); Regeneron (Inst); Seagen (Inst); Trillium Therapeutics (Inst)
 
Tufia C. Haddad
Research Funding - Takeda (Inst)
 
Yi Lin
Consulting or Advisory Role - Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Gamida Cell (Inst); Janssen Oncology (Inst); Juno Therapeutics (Inst); Kite/Gilead (Inst); Legend Biotech (Inst); Novartis (Inst); Sorrento Therapeutics (Inst); Vineti (Inst)
Research Funding - Bluebird Bio (Inst); Boston Scientific (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Janssen Oncology (Inst); Kite/Gilead (Inst); Merck (Inst); Takeda (Inst)